#136. What Do You Get When You Bring Three Executive Directors Together? The Pink Umbrella

Love the episode? Send us a text!

Today on Breast Cancer Conversations I'm joined by Dr. Bardia, a Board Certified Medical Oncologist interested in developing successful, targeted and personalized therapies to improve the outcomes of patients and families affected by breast cancer.
Dr. Bardia is involved in clinical development of tumor genotyping, as well as circulating tumor cells to facilitate accurate diagnosis, therapy selection, and real time monitoring of breast cancer. Dr. Bardia is the primary investigator of clinical trials investigating the role of targeted therapy combinations for breast cancer, and is the recipient of the Young Investigator Award from ASCO Conquer Cancer Foundation.
I am also joined by two other amazing women, Janice Cowden and Keegan Hitchcock, both living with metastatic TNBC. Janice was diagnosed with stage four metastatic triple negative breast cancer in 2016. With a 20 plus year background in nursing, science, research and studying disease, it is no surprise that Janice became a Patient Advocate. Her advocacy work has included working with organizations like METAvivor, Living Beyond Breast Cancer, ABCD after breast cancer diagnosis, among others.
I am also so excited because I am joined by Keegan Hitchcock. Keegan is 41 years old, born and raised in Florida, where she had a professional career as a face and body painter for over 20 years. Her interests include reading and consuming lots of podcasts, including anything from spooky stories and humor, to the lesser known history, critical thinking and science. She loves watching and discussing nerdy TV shows and movies with friends, roller-skating, and spoiling her two cats. She now lives in Maryland near family where she continues to work at a national health food store doing price integrity. Her original diagnosis was in May of 2019 with stage three triple negative invasive ductal carcinoma. As of April 2021, she has been re-diagnosed with a recurrence stage four metastatic triple negative breast cancer.

Welcome to the conversation.

Listen on: Apple Podcasts Spotify

Support the show